Skip to main content

Revance Therapeutics, Inc. (NASDAQ: RVNC) Investor Securities Class Action Lawsuit 12/10/2021

  • If you purchased a significant amount of shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November 25, 2019 and October 11, 2021, and / or if you purchased any NASDAQ: RVNC shares prior to November 2019 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: February 8, 2022. NASDAQ: RVNC investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April 2, 2024 - The court issued an order granting motion to dismiss. Leave was given to amend the complaint. January 23, 2023 - A motion was filed to dismiss the amended complaint. November 7, 2022 - An amended complaint was filed. December 10, 2021 - An investor in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) filed a lawsuit in the U.S. District Court for the Northern Distric...



You must register (for free) or login to view the entire case.